Abstract:Significance Statement Emerging evidence suggests that melanocortin neuropeptides—specifically adrenocorticotropic hormone—offer a novel, steroidogenic-independent therapeutic modality for membranous nephropathy (MN). The molecular mechanism underlying this beneficial effect, however, remains largely elusive. To investigate whether melanocortins modulate humoral immunity, the authors induced passive Heymann nephritis, a model of human MN, in wild-type and melanocortin 1 receptor (MC1R) knockout rats and treated them with melanocortin agents. Additional rats received adoptive transfer of bone marrow-derived cells beforehand from wild-type or MC1R knockout rats. The findings indicate that MC1R signaling plays a key role in negative modulation of B-cell activation and thereby suppresses humoral immune responses in passive Heymann nephritis, and suggest that MC1R signaling might offer a novel B cell–targeted therapeutic strategy for MN. Background Emerging evidence suggests that the pituitary neuropeptide melanocortins—specifically, adrenocorticotropic hormone—offer a novel nonsteroidogenic therapeutic modality for membranous nephropathy (MN). However, the mechanism(s) of action remains elusive. Methods To investigate whether melanocortins modulate humoral immunity, we induced passive Heymann nephritis (PHN), a model of MN, in wild-type (WT) and melanocortin 1 receptor (MC1R) knockout (KO) rats. We treated the animals with melanocortin agents—repository corticotropin injection, the nonsteroidogenic pan-melanocortin receptor agonist [Nle4, DPhe7]-α-melanocyte stimulating hormone, the selective MC1R agonist MS05, vehicle gel, or phosphate-buffered saline—and evaluated kidney function, histology, and molecular changes. Additional rats received adoptive transfer of syngeneic bone marrow-derived cells beforehand from WT or MC1R KO rats. Results KO of MC1R worsened PHN and this was associated with increased deposition of autologous immunoglobulin G (IgG) and complement C5b-9 in glomeruli and higher circulating levels of autologous IgG—evidence of a sensitized humoral immune response. Melanocortin therapy ameliorated PHN in WT rats, coinciding with reduced glomerular deposition of autologous IgG and C5b -9. The beneficial efficacy of melanocortins was blunted in KO rats but restored by adoptive transfer of syngeneic bone marrow-derived cells derived from WT rats. Mechanistically, MC1R was expressed in B lymphocytes and was negatively associated with B cell activation. MC1R agonism triggered the expression of microphthalmia-associated transcription factor in activated B cells in a cAMP-dependent mode and also repressed the expression of interferon regulatory factor 4 (a lymphoid transcription factor essential for B-cell development and maturation), resulting in suppressed plasma cell differentiation and IgG production. Conclusions MC1R signaling negatively modulates B cell activation and suppresses humoral immune responses in PHN, suggesting that MC1R signaling might offer a novel therapeutic target for MN.

Subthreshold activation of the melanocortin system causes generalized sensitization to anorectic agents in mice

Cell autonomous regulation of the activation of AgRP neurons by the melanocortin-3 receptor

Melanocortin-3 receptor expression in AgRP neurons is required for normal activation of the neurons in response to energy deficiency

A Gut-Intrinsic Melanocortin Signaling Complex Augments L-Cell Secretion in Humans

Neuroanatomical dissection of the MC3R circuitry regulating energy rheostasis

A neural basis for melanocortin-4 receptor-regulated appetite

Melanocortin Receptor-4 Mediates the Anorectic Effect Induced by the Nucleus Tractus Solitarius Injection of Glucagon-Like Peptide-2 in Fasted Rats.

Prefrontal cortex melanocortin 4 receptors (MC4R) mediate food intake behavior in male mice

Melanocortin 4 Receptors Reciprocally Regulate Sympathetic and Parasympathetic Preganglionic Neurons

Divergence of melanocortin pathways in the control of food intake and energy expenditure.

Hindbrain melanocortin 3/4 receptors modulate the food intake and body weight suppressive effects of the GLP-1 receptor agonist, liraglutide

Synaptic organization between melanocortin-4 receptor-expressing neurons in the dorsal motor nucleus of the vagus nerve and enteric ganglia neurons in the mouse

[Regulation of appetite by melanocortin and its receptors]

A human obesity-associated MC4R mutation with defective Gq/11α signaling leads to hyperphagia in mice

The adipose tissue melanocortin 3 receptor is targeted by ghrelin and leptin and may be a therapeutic target in obesity

Melanocortin 4 receptor signals at the neuronal primary cilium to control food intake and body weight

Melanocortin Activation of Nucleus of the Solitary Tract Avoids Anorectic Tachyphylaxis and Induces Prolonged Weight Loss.

Negative Modulation of B Cell Activation by Melanocortin 1 Receptor Signaling Protects Against Membranous Nephropathy

Deletion of Melanin Concentrating Hormone Receptor-1 disrupts overeating in the presence of food cues

Melanocortin 3/4 receptors in paraventricular nucleus modulate sympathetic outflow and blood pressure

Agrp Neurons Mediate Sirt1's Action on the Melanocortin System and Energy Balance: Roles for Sirt1 in Neuronal Firing and Synaptic Plasticity.